Reyna, Sandra P.
Novartis Gene Therapies, Inc. (United States)
2 papers on CoChat
Most cited papers
- Verified
Thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy: a case series
Chand, D. H., Zaidman, C., Arya, K., Millner, R., Farrar, M. A., Mackie, F. E., Goedeker, N. L., Dharnidharka, V. R., Dandamudi, R., & Reyna, S. P. (2021) · The Journal of Pediatrics
Complement system in diseasesNeurogenetic and Muscular Disorders Research
Cited by 210
- Verified
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
Day, J. W., Mendell, J. R., Mercuri, E., Finkel, R. S., Strauss, K. A., Kleyn, A., Tauscher-Wisniewski, S., Tukov, F. F., Reyna, S. P., & Chand, D. H. (2021) · Drug Safety
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 119
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free